FDA approves new dosing of Lilly’s Alzheimer’s drug Kisunla to lower brain swelling risksnews2025-07-09T10:45:52+00:00July 9th, 2025|Endpoints News|
Trump hints at tariff grace period for pharma companies to onshore manufacturingnews2025-07-08T19:23:54+00:00July 8th, 2025|Endpoints News|
Otsuka’s Taiho reports Phase 3 fail for Duchenne muscular dystrophy drugnews2025-07-08T19:09:32+00:00July 8th, 2025|Endpoints News|
In first half of 2025, novel drug approvals are in line with previous yearsnews2025-07-08T18:35:31+00:00July 8th, 2025|Endpoints News|
The highest-paid pharma and biotech CEOs of 2024news2025-07-08T14:00:05+00:00July 8th, 2025|Endpoints News|
Novartis maps launch of malaria drug for newborns after Swiss approvalnews2025-07-08T05:15:03+00:00July 8th, 2025|Endpoints News|
Doctors sue RFK Jr., HHS over changes to Covid-19 vaccine schedulenews2025-07-07T19:34:38+00:00July 7th, 2025|Endpoints News|
Trump’s tax cut law expands orphan drug exclusions, could upend 340B programnews2025-07-07T19:14:19+00:00July 7th, 2025|Endpoints News|
The fight over state PBM laws will continue after Supreme Court denial news2025-07-07T18:26:38+00:00July 7th, 2025|Endpoints News|
KalVista CEO talks FDA drug approval, review delaynews2025-07-07T18:05:10+00:00July 7th, 2025|Endpoints News|
